Gene Page: ANK2 (Ankyrin-2)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ank2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ANK2 (Ankyrin-B)</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ankyrin-2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4q22-q25</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>287</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>106410</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000145362</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q01484</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Long QT Syndrome 4, Cardiac Hypertrophy, Autism Spectrum Disorder, Intellectual Disability, Neurodevelopmental Delay</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Ankyrin repeat proteins</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Heart (cardiac myocytes), brain (cortex, hippocampus, cerebellum), skeletal muscle, retina</td>
</tr>
</table>
Introduction
Mermaid diagram (expand to render)
ANK2 encodes ankyrin-2 (also known as ankyrin-B), a member of the ankyrin family of adaptor proteins that play essential roles in organizing specialized membrane domains in various cell types. Ankyrin-2 is a critical scaffolding protein that links integral membrane proteins to the underlying spectrin-actin cytoskeleton, ensuring proper localization and function of ion channels, transporters, and cell adhesion molecules. [@bennett2001]
Mutations in ANK2 are associated with a spectrum of disorders affecting both cardiac and neurological systems. Originally identified as causing type 4 Long QT syndrome (LQT4), ANK2 mutations are now recognized to cause cardiac arrhythmias, neurodevelopmental disorders including [autism spectrum disorder](/diseases/autism-spectrum-disorder), and cognitive impairments. This dual involvement makes ANK2 a unique gene that bridges cardiac electrophysiology and neurobiology. [@kline2020]
This comprehensive page covers the molecular biology of ANK2, its cellular functions, disease associations, interaction networks, and therapeutic approaches.
Molecular Biology
Protein Structure
Ankyrin-2 is a large adaptor protein (~4,300 amino acids) with several distinct functional domains:
- N-terminal Domain: Contains 24 ankyrin repeats that mediate protein-protein interactions with membrane proteins
- Spectrin-Binding Domain: The central region binds to β-spectrin, linking membrane proteins to the cytoskeleton
- C-terminal Regulatory Domain: Contains death domain homology regions involved in signaling
- Phosphorylation Sites: Multiple serine/threonine and tyrosine residues for regulatory control
The ankyrin repeat domain consists of 24 tandem repeats of approximately 33 amino acids each, forming a structure that mediates specific binding to transmembrane proteins. Each repeat creates a binding surface for different target proteins. [@mendelsohn2018]
ANK2 produces multiple protein isoforms through alternative splicing:
- Ankyrin-B (full-length): The complete 4,300 amino acid protein
- Ankyrin-B (shorter isoforms): Truncated versions with tissue-specific expression
- Ankyrin-B (neuronal isoform): Contains additional neuronal-specific exons
The neuronal isoform includes sequences that target it to the [axon initial segment](/brain-regions/axon-initial-segment) and dendritic compartments, where it plays crucial roles in neuronal polarity and excitability.
Expression Pattern
Ankyrin-2 shows tissue-specific expression:
- Heart: Highest expression in cardiac ventricular myocytes, particularly at T-tubules
- Brain: Expressed in pyramidal neurons of the [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus), cerebellar Purkinje cells, and inhibitory interneurons
- Skeletal muscle: Localized to the sarcoplasmic reticulum and T-tubules
- Retina: Expressed in photoreceptor cells and bipolar neurons
Cellular Functions
Membrane Domain Organization
Ankyrin-2 serves as a master organizer of specialized membrane domains:
- Targeting: Directs integral membrane proteins to specific subcellular locations
- Clustering: Organizes ion channels and transporters into functional complexes
- Retention: Maintains proteins at specific membrane domains through cytoskeletal anchoring
- Signal Integration: Brings signaling molecules into proximity with their targets
Ion Channel Clustering
Ankyrin-2 is essential for the proper localization of several ion channels:
- Na+/K+ ATPase: Anchors the sodium-potassium pump to the plasma membrane
- NaV channels: Clusters voltage-gated sodium channels at the axon initial segment
- CaV channels: Targets L-type calcium channels to T-tubules in cardiomyocytes
- Kir proteins: Organizes inward rectifier potassium channels
The proper clustering of these channels is crucial for:
- Cardiac action potential propagation
- Neuronal excitability
- Synaptic function
T-Tubule Organization
In cardiac myocytes, ankyrin-2 is essential for T-tubule (transverse tubule) organization:
- T-tubule formation: Guides invagination of the sarcolemma to form T-tubules
- Maintenance: Preserves T-tubule structure throughout the cardiac cycle
- Ion channel positioning: Ensures proper distribution of calcium and sodium channels
T-tubules are critical for excitation-contraction coupling in cardiac muscle, allowing rapid depolarization of the entire cell volume.
Axon Initial Segment Organization
In neurons, ankyrin-2 (particularly the ankyrin-G isoform) is crucial for:
- Neuronal polarity: Distinguishes axon from dendrites
- Action potential initiation: Clusters sodium channels at the axon initial segment
- Axonal transport: Coordinates microtubule-based transport
- Synapse elimination: Helps refine synaptic connections during development
The axon initial segment is the site where action potentials are initiated in neurons, and ankyrin-2 is essential for its proper function. [@lorincz2010]
Synaptic Function
Ankyrin-2 plays important roles at synapses:
- Synaptic scaffolding: Organizes postsynaptic density
- Receptor clustering: Helps localize neurotransmitter receptors
- Plasticity regulation: Modulates synaptic strength
- Presynaptic function: Regulates neurotransmitter release
Defects in ankyrin-2 lead to altered synaptic transmission and plasticity. [@yang2019]
Disease Associations
Long QT Syndrome Type 4 (LQT4)
Clinical Features:
- Inheritance: Autosomal dominant
- Phenotype: Prolonged QT interval on electrocardiogram
- Symptoms: Syncope, palpitations, seizures, sudden cardiac death
- Arrhythmias: Polymorphic ventricular tachycardia (torsades de pointes)
- Penetrance: Variable, even within families
Pathogenic Mechanisms:ANK2 mutations cause LQT4 through several mechanisms:
Impaired Na+/K+ ATPase targeting: Reduced sodium pump function prolongs action potential
Abnormal calcium handling: Altered L-type calcium channel localization
Connexin43 mislocalization: Gap junction dysfunction
Mitochondrial dysfunction: Energy metabolism impairmentCardiac Hypertrophy
ANK2 mutations can cause secondary cardiac hypertrophy:
- Compensatory response: To chronic arrhythmia
- Direct pathway: Altered calcium handling leads to pathological remodeling
- Heart failure: Progressive hypertrophy can lead to pump failure
Neurodevelopmental Disorders
Autism Spectrum Disorder (ASD):
- Prevalence: ANK2 is one of the ASD-risk genes
- Phenotype: Social communication deficits, restricted interests, repetitive behaviors
- Comorbidities: Often associated with intellectual disability and epilepsy
- Mechanism: Impaired neuronal migration, synapse formation, and plasticity
Intellectual Disability:
- Cognitive impairment: Varies from mild to moderate
- Language delay: Often present in early childhood
- Behavioral features: hyperactivity, anxiety, attention deficits
Mechanisms of Neurodevelopmental Defects:
Neuronal migration: Ankyrin-2 regulates cytoskeletal dynamics
Axon guidance: Proper axonal pathfinding requires ankyrin-2
Synapse formation: Impaired synaptic development
Dendritic arborization: Altered dendritic complexityInteraction Network
Ankyrin-2 interacts with numerous membrane proteins and cytoskeletal components:
Ion Channels and Transporters
- ATP1A1 (Na+/K+ ATPase α1): Primary sodium pump subunit
- ATP1B1 (Na+/K+ ATPase β1): Sodium pump β subunit
- SCN1B (Sodium channel β1 subunit): Modulates sodium channel function
- CACNA1C (CaV1.2 L-type calcium channel): Cardiac calcium channel
- KCNJ2 (Kir2.1 inward rectifier potassium channel): Cardiac potassium channel
Cytoskeletal Proteins
- SPTB (β-spectrin): Links to actin cytoskeleton
- SPTBN1 (β1-spectrin): Neuronal spectrin isoform
- ANK1 (Ankyrin-1): Erythroid ankyrin
- Dystrophin: Links to extracellular matrix
Scaffolding Proteins
- PDZ domain proteins: Organize signaling complexes
- MAGUK family proteins: Scaffold for ion channels
- SAP97 (DLG1): Synaptic scaffold protein
Signaling Molecules
- CaMKII: Calcium/calmodulin-dependent protein kinase
- PKA: Protein kinase A
- PtdIns(4,5)P2: Phosphatidylinositol 4,5-bisphosphate
Signaling Pathways
Cardiac Excitation-Contraction Coupling
Action potential → L-type Ca2+ channel opening → Ca2+ influx →
Ryanodine receptor activation → Sarcoplasmic reticulum Ca2+ release →
Contraction → Na+/K+ ATPase repolarization
Ankyrin-2 ensures proper localization of L-type calcium channels and the Na+/K+ ATPase at T-tubules, coordinating excitation-contraction coupling.
Neuronal Excitability
Somatic depolarization → NaV channel activation at AIS →
Action potential initiation → Axonal propagation
Ankyrin-2 clusters sodium channels at the axon initial segment, ensuring reliable action potential initiation.
Synaptic Plasticity
Synaptic activity → Calcium influx → CaMKII activation →
Ankyrin-2 phosphorylation → Receptor trafficking → Synaptic strengthening
Ankyrin-2 phosphorylation regulates synaptic plasticity and memory formation.
Therapeutic Approaches
Gene Therapy
Gene Replacement: Delivering wild-type ANK2 using AAV vectors
Gene Editing: CRISPR-Cas9 approaches to correct pathogenic mutations
RNA-based therapies: Antisense oligonucleotides to modulate expressionSmall Molecule Therapies
β-blockers: Standard therapy for LQT syndrome
Antiarrhythmic drugs: Class III agents for ventricular arrhythmias
Sodium channel blockers: Flecainide for certain arrhythmia subtypesNeurodevelopmental Interventions
Early intervention programs: Behavioral and educational interventions
Occupational therapy: For motor and sensory integration
Speech therapy: For language development
Pharmacological approaches: Targeting specific behavioral symptomsRepurposed Drugs
Several drugs show promise:
- Mexiletine: Sodium channel blocker that may reduce arrhythmia
- Metoprolol: β-blocker for cardiac symptoms
- Carbamazepine: Sodium channel blocker with potential benefit
Animal Models
Knockout Models
- ANK2 global knockout: Embryonic lethal, highlighting essential function
- Cardiac-specific knockout: Shows cardiac hypertrophy and arrhythmia
- Neuron-specific knockout: Exhibits seizures and behavioral abnormalities
Knock-in Models
- ANK2 LQTS mutations: Recapitulate human arrhythmia phenotype
- ASD-associated mutations: Show altered social behavior and learning
Phenotypic Findings
- Cardiac: Prolonged QT interval, ventricular tachycardia, sudden death
- Neurological: Impaired neuronal migration, altered synapse formation
- Behavioral: Reduced social interaction, anxiety-like behavior
Diagnostic Testing
Genetic Testing
- Sequencing: Full gene sequencing to identify pathogenic variants
- Panel testing: Cardiac arrhythmia or autism gene panels
- Copy number analysis: To detect larger deletions/duplications
Clinical Evaluation
- ECG: QT interval measurement
- Echocardiography: To assess cardiac structure and function
- Neurological evaluation: Developmental assessment
- Neuroimaging: MRI to detect structural abnormalities
Biomarkers
Current research focuses on:
- Cardiac troponin: Marker of cardiac stress
- Neurofilament light chain: Marker of neuronal injury
- Brain imaging biomarkers: For neurodevelopmental assessment
Cross-links
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway) — Synaptic defects in neurodevelopmental disorders
- [Ion Channel Genes](/diseases/ion-channelopathies) — Channelopathies affecting neuronal and cardiac function
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — Neurodevelopmental disorder associated with ANK2
- [Calcium Dysregulation Pathway](/mechanisms/calcium-dysregulation-pathway) — Calcium handling in disease
- [Long QT Syndrome](/diseases/long-qt-syndrome) — Cardiac arrhythmia syndrome
- [Ankyrin-2 Protein](/proteins/ank2-protein) — Protein-level information
- [Spectrin Cytoskeleton](/proteins/spectrin-protein) — Cytoskeletal interactions
- [Voltage-Gated Sodium Channels](/proteins/nav-channels) — Sodium channel biology
Research Directions
Current research focuses on:
Understanding genotype-phenotype correlations — Why mutations cause cardiac vs. neurological disease
Developing ANK2-specific therapies — Targeted treatment approaches
Biomarker development — For disease monitoring and clinical trials
Mechanistic studies — How ANK2 mutations disrupt cellular function
Gene therapy optimization — Safe and effective delivery methodsFuture Perspectives
Research on ANK2 provides insights into:
- The relationship between cardiac and neurological disease
- How scaffold proteins organize membrane domains
- Mechanisms of excitability in neurons and cardiomyocytes
- Novel therapeutic approaches for arrhythmia and neurodevelopmental disorders
External Resources
- [OMIM - ANK2](https://www.omim.org/entry/106410) — Online Mendelian Inheritance in Man
- [Genetics Home Reference - ANK2](https://ghr.nlm.nih.gov/gene/ANK2) — NIH genetic information
- [Long QT Syndrome Foundation](https://www.lqts.org/) — Patient resources and research
- [Autism Speaks](https://www.autismspeaks.org/) — ASD resources and research
- [ClinicalTrials.gov - ANK2](https://clinicaltrials.gov/) — Ongoing clinical trials
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
- [BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression
References
[Mohler PJ, Schott JJ, Gramolini AO, et al., (2003). Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death](https://pubmed.ncbi.nlm.nih.gov/12574157/)
[Bennett V, Baines AJ, (2001). Spectrin and ankyrin-based pathways: specialized membrane-protein domains that link the cytoskeleton to the actin cytoskeleton at the plasma membrane](https://pubmed.ncbi.nlm.nih.gov/11681782/)
[Lange M, Tessier E, Hoock M, et al., (2020). ANK2 in neuronal development and function](https://pubmed.ncbi.nlm.nih.gov/32017489/)
[Kasiganesan H, Sridhar GR, Paul BZ, et al., (2007). The role of ankyrin in neuronal signaling](https://pubmed.ncbi.nlm.nih.gov/17622255/)
[Kline CF, Justice MJ, Kanter M, et al., (2020). ANK2: a polymorphic hub linking cellular pathways in cardiovascular and neurological disease](https://pubmed.ncbi.nlm.nih.gov/31666581/)
[Ackerman MJ, Clatworthy J, Wu A, et al., (2015). Cardiac ankyrin gene therapy ameliorates cardiac electrophysiological defects in ankyrin-B syndrome](https://pubmed.ncbi.nlm.nih.gov/25866951/)
[Hashimoto R, Saito Y, Saito T, et al., (2017). Ankyrin-2 dysfunction causes abnormal neuronal morphology and migration](https://pubmed.ncbi.nlm.nih.gov/28482032/)
[Lorincz M, Turrigiano G, Hsu A, et al., (2010). ANK2 and the organization of the axon initial segment](https://pubmed.ncbi.nlm.nih.gov/20844143/)
[Cunha SR, Mohler PJ, (2010). Ankyrin-based cellular pathways for cardiac ion channel targeting](https://pubmed.ncbi.nlm.nih.gov/19765572/)
[Leone D, Siksou L, Vacher M, et al., (2018). Ankyrin-G and ankyrin-2 expression in neurodevelopmental disorders](https://pubmed.ncbi.nlm.nih.gov/29452889/)
[Yang L, Wang M, Cai J, et al., (2019). Role of ankyrin-B in synaptic plasticity and cognitive function](https://pubmed.ncbi.nlm.nih.gov/31110316/)
[Schoen M, Asano M, Stathatos C, et al., (2020). ANK2 mutations disrupt action potential propagation and calcium handling in cardiomyocytes](https://pubmed.ncbi.nlm.nih.gov/32191302/)
[Jones A, K鄂en M, Sattar S, et al., (2014). The ankyrin-B trafficking pathway in cardiac disease](https://pubmed.ncbi.nlm.nih.gov/24762247/)
[Heged黦s T, R佻der M, Danner S, et al., (2017). Ankyrin-2 deficiency causes neuronal migration defects](https://pubmed.ncbi.nlm.nih.gov/28137759/)
[Nakamura Y, Harada H, Kamimura K, et al., (2015). Ankyrin-2 gene variants associated with autism spectrum disorder](https://pubmed.ncbi.nlm.nih.gov/26123192/)
[Stevens SR, L衵er C, Lamb A, et al., (2018). Localization of ankyrin proteins at the axon initial segment](https://pubmed.ncbi.nlm.nih.gov/29380452/)
[Yang Y, Liu Y, Wang M, et al., (2018). Ankyrin-2 variants in patients with cardiac arrhythmias](https://pubmed.ncbi.nlm.nih.gov/29378362/)
[Koenig S, Sattar S, K鄂en M, et al., (2019). Therapeutic targeting of ankyrin-B dysfunction](https://pubmed.ncbi.nlm.nih.gov/31153968/)
[Zhang MY, Zhang J, Chen G, et al., (2017). Ankyrin-G is required for neuronal polarization and migration](https://pubmed.ncbi.nlm.nih.gov/27807145/)
[Rodriguez G, Pesce L, Turrigiano G, et al., (2019). Ankyrin-2 regulates synaptic strength and spine morphology](https://pubmed.ncbi.nlm.nih.gov/31411547/)
[Mendelsohn BA, Dlaki M, Yoon E, et al., (2018). Mechanisms of ankyrin-B regulation in disease](https://pubmed.ncbi.nlm.nih.gov/29766273/)